169 related articles for article (PubMed ID: 23430692)
1. Modeling human protein aggregation cardiomyopathy using murine induced pluripotent stem cells.
Limphong P; Zhang H; Christians E; Liu Q; Riedel M; Ivey K; Cheng P; Mitzelfelt K; Taylor G; Winge D; Srivastava D; Benjamin I
Stem Cells Transl Med; 2013 Mar; 2(3):161-6. PubMed ID: 23430692
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
[TBL] [Abstract][Full Text] [Related]
3. Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation.
Mori H; Xu D; Shimoda Y; Yuan Z; Murakata Y; Xi B; Sato K; Yamamoto M; Tajiri K; Ishizu T; Ieda M; Murakoshi N
Sci Rep; 2024 Jul; 14(1):15422. PubMed ID: 38965264
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline attenuates protein aggregation in cardiomyocytes and improves survival of a mouse model of cardiac proteinopathy.
Zheng H; Tang M; Zheng Q; Kumarapeli AR; Horak KM; Tian Z; Wang X
J Am Coll Cardiol; 2010 Oct; 56(17):1418-26. PubMed ID: 20947000
[TBL] [Abstract][Full Text] [Related]
5. Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.
Cashman TJ; Josowitz R; Johnson BV; Gelb BD; Costa KD
PLoS One; 2016; 11(1):e0146697. PubMed ID: 26784941
[TBL] [Abstract][Full Text] [Related]
6. Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations.
Zhou W; Bos JM; Ye D; Tester DJ; Hrstka S; Maleszewski JJ; Ommen SR; Nishimura RA; Schaff HV; Kim CS; Ackerman MJ
J Cardiovasc Transl Res; 2019 Oct; 12(5):394-403. PubMed ID: 30796699
[TBL] [Abstract][Full Text] [Related]
7. Establishing a new human hypertrophic cardiomyopathy-specific model using human embryonic stem cells.
Cai H; Li B; Bai A; Huang J; Zhan Y; Sun N; Liang Q; Xu C
Exp Cell Res; 2020 Feb; 387(1):111736. PubMed ID: 31759053
[TBL] [Abstract][Full Text] [Related]
8. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
[TBL] [Abstract][Full Text] [Related]
9. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice.
Wang X; Osinska H; Klevitsky R; Gerdes AM; Nieman M; Lorenz J; Hewett T; Robbins J
Circ Res; 2001 Jul; 89(1):84-91. PubMed ID: 11440982
[TBL] [Abstract][Full Text] [Related]
10. Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice.
Keller K; Maass M; Dizayee S; Leiss V; Annala S; Köth J; Seemann WK; Müller-Ehmsen J; Mohr K; Nürnberg B; Engelhardt S; Herzig S; Birnbaumer L; Matthes J
Cardiovasc Res; 2015 Dec; 108(3):348-56. PubMed ID: 26464333
[TBL] [Abstract][Full Text] [Related]
11. The Human 343delT HSPB5 Chaperone Associated with Early-onset Skeletal Myopathy Causes Defects in Protein Solubility.
Mitzelfelt KA; Limphong P; Choi MJ; Kondrat FD; Lai S; Kolander KD; Kwok WM; Dai Q; Grzybowski MN; Zhang H; Taylor GM; Lui Q; Thao MT; Hudson JA; Barresi R; Bushby K; Jungbluth H; Wraige E; Geurts AM; Benesch JL; Riedel M; Christians ES; Minella AC; Benjamin IJ
J Biol Chem; 2016 Jul; 291(29):14939-53. PubMed ID: 27226619
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of α-crystallinopathy and its therapeutic strategy.
Sanbe A
Biol Pharm Bull; 2011; 34(11):1653-8. PubMed ID: 22040875
[TBL] [Abstract][Full Text] [Related]
13. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
[TBL] [Abstract][Full Text] [Related]
14. Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy.
Dementyeva EV; Medvedev SP; Kovalenko VR; Vyatkin YV; Kretov EI; Slotvitsky MM; Shtokalo DN; Pokushalov EA; Zakian SM
Biochemistry (Mosc); 2019 Mar; 84(3):291-298. PubMed ID: 31221067
[TBL] [Abstract][Full Text] [Related]
15. Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.
Li J; Feng X; Wei X
Stem Cell Res Ther; 2022 Jun; 13(1):232. PubMed ID: 35659761
[TBL] [Abstract][Full Text] [Related]
16. Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation.
Ribeiro M; Jager J; Furtado M; Carvalho T; Cabral JMS; Brito D; Carmo-Fonseca M; Martins S; da Rocha ST
Hum Cell; 2024 Jul; 37(4):1205-1214. PubMed ID: 38762696
[TBL] [Abstract][Full Text] [Related]
17. Optimization and enrichment of induced cardiomyocytes derived from mouse fibroblasts by reprogramming with cardiac transcription factors.
Tian J; Wang R; Hou Q; Li M; Chen L; Deng X; Zhu Z; Zhao Y; He W; Fu X
Mol Med Rep; 2018 Mar; 17(3):3912-3920. PubMed ID: 29257325
[TBL] [Abstract][Full Text] [Related]
18. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
Nelson TJ; Balza R; Xiao Q; Misra RP
J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
[TBL] [Abstract][Full Text] [Related]
19. Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomyopathy.
Maloyan A; Gulick J; Glabe CG; Kayed R; Robbins J
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5995-6000. PubMed ID: 17389375
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation.
Li S; Pan H; Tan C; Sun Y; Song Y; Zhang X; Yang W; Wang X; Li D; Dai Y; Ma Q; Xu C; Zhu X; Kang L; Fu Y; Xu X; Shu J; Zhou N; Han F; Qin D; Huang W; Liu Z; Yan Q
Stem Cell Reports; 2018 Mar; 10(3):808-821. PubMed ID: 29456182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
